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What are ͚Critically Appraised Topics͛? 
Routine clinical practice often generates challenging questions about how to provide the best care 
for individual patients. For example, as dermatologists we may wonder whether ultrapotent topical 
corticosteroids are more effective in the treatment of alopecia areata than triamcinolone injections. 
Sometimes such questions might come directly from our patients: ͚DoĐtoƌ, I have read about acne 
treatments on the internet. Is it true that isotƌetiŶoiŶ Đauses depƌessioŶ?͛ oƌ ͚Hoǁ safe ǁould 
ŵaiŶteŶaŶĐe ultƌaǀiolet B light theƌapǇ ďe to ĐoŶtƌol ŵǇ atopiĐ eĐzeŵa?͛  
Guidelines rarely provide the answers to these very specific questions. A systematic review is not 
feasible for every question that arises in the clinic, and quick internet searches are neither 
comprehensive nor reliable.  
This is the gap that critically appraised topics (CATs) address. CATs are standardized summaries 
which draw together the best available evidence to answer questions based on real clinical scenarios 
often arising from specific patient encounters. CATs embrace the principles of evidence-based 
medicine (EBM) by following all four steps in EBM steps, but in a less rigorous and time consuming 
way. Since CATS focus on specific clinical scenarios, this creates a synthesis that generates new 
insights and knowledge.  
Why are CATs useful?  
CATs ensure that we use the highest quality, most up-to-date evidence help us address questions 
that arise organically and repeatedly in clinical practice. CATs help us to benefit from the rapidly 
increasing but potentially overwhelming volume of information now available.1 Additionally, they 
help readers and authors develop skills in critically appraising literature. 
CATs are not intended to replace rigorously designed and comprehensive systematic reviews, as 
they do not attempt to include all of the available evidence. Systematic reviews remain the gold 
standard for summarizing evidence but are often too time-consuming and costly to carry out for all 
clinical questions. In contrast, CATs are more focused, quicker to complete and can be done with a 
small team of authors at minimal cost. CATs, in comparison, are a more practical tool to address the 
many questions that are not considered by systematic reviews and guidelines. Like systematic 
reviews, CATs facilitate the integration of clinical research with clinical practice and avoid or 
minimise biases inherent with narrative reviews or internet searches.   
 
CATs: background and future vision  
CATs are well established in various specialities including radiology, neurology, emergency medicine 
and palliative care.2-5 They were introduced to dermatology in 20076, and subsequently embraced by 
the BJD as ͚shoƌt suŵŵaƌies of eǀideŶĐe oŶ a topiĐ of iŶteƌest....foĐused aƌouŶd a ĐliŶiĐal sĐeŶaƌio͛. 7 
Noǁ, aloŶgside ͚PuttiŶg Papeƌs iŶto PƌaĐtiĐe' aŶd “ǇsteŵatiĐ ‘eǀieǁs, CATs foƌŵ a keǇ eleŵeŶt of 
the Evidence-Based Dermatology section of the BJD.  This article aims to help dermatologists and 
residents carry out their own CATs by describing the steps involved. Our vision is for CATs to become 
an increasingly important element of this section of the journal, creating an accessible resource of 
relevance and utility to daily clinical practice globally. 
 How to perform a CAT  
There are four main steps to complete a CAT, identical to the steps in EBM. the first of which is to 
geŶeƌate a stƌuĐtuƌed ƋuestioŶ fƌoŵ the ĐliŶiĐal eŶĐouŶteƌ usiŶg the ͚PopulatioŶ, IŶteƌǀeŶtioŶ, 
Coŵpaƌatoƌ, OutĐoŵe͛ oƌ ͚PICO͛ format (table 1). Each of the four steps will now be described in 
more detail. 
1. Formation of a focused and answerable question based on a clinical encounter  
2. Search for the best available evidence  
3.Critical appraisal of the evidence for validity and clinical relevance 
4. Interpreting and applying the results to clinical practice 
Table 1: Steps in performing a critically appraised topic (CAT).   
Formation of a PICO question 
Most questions arising from clinical practice relate to a specific treatment, diagnostic test or harmful 
agent. The systematic search for evidence about a topic requires a carefully formulated question   
Population [P]: The PICO question requires a definition of the group of people with a disease or 
characteristic of interest. As  the evidence must be applicable to this population, the P should be 
well specified  , For example, age or gender, disease stage, disease severity, disease localisation or 
extent, related symptoms, co-morbidities, the effect of previous treatments, and current or future 
pregnancy could each be considered important in the scenario and should therefore be specified in 
the patient population component. An example of a specific population to use in a CAT is: a 
paediatric patient with severe psoriasis, unresponsive to topical treatments. 
Intervention(s) [I]: Originally, when the acronym PICO was developed I related to treatments, but I 
can relate to a risk factor in questions about aetiology or prognosis and a diagnostic test in diagnosis. 
The I may include specific details such as treatment dose, duration and frequency of a therapy, 
mode of administration or a combination of therapies.  Alternatively, it might concern the timing of 
a specific diagnostic test or a combination of tests. An example of an intervention in our case would 
be: treatment with narrow band UVB phototherapy three times per week for eight weeks  
Comparator [C]: The comparator in a PICO question concerns the treatment or diagnostic test that 
the intervention treatment or test is compared to. For example, the specific alternative treatment 
might be no treatment or placebo or other possible treatments, such as oral methotrexate for our 
paediatric patient with psoriasis. When analysing the utility of a specific diagnostic test, a reference 
standard diagnostic test should be chosen as the comparator, such as procollagen III and liver 
function tests measured every three months compared to liver function tests alone.  
Outcome:  The outcome in a PICO question requires definition and might be short- or long-term 
physician assessed efficacy, specific patient-reported outcomes, adverse event rates or diagnostic 
accuracy (sensitivity and specificity). Outcomes in a PICO question may be multiple and can be 
divided into critically important, important and less important. An example of an outcome in a PICO 
question would be: reduction in PASI by 75% or greater after three months of treatment compared 
to baseline. In questions about harm the outcome is often a disease. 
In summary, the careful construction of a clinical question using the PICO format ensures that the 
CAT remains linked to the original clinical scenario encountered and facilitates subsequent focused 
searching for the relevant evidence. Examples of PICO questions from CATs published in the BJD are 
shown in Table 2.8-12 
Finding the best available evidence: where to start searching 
 
 
 Figure 1. 6S Evidence pyramid adapted from DiCenso A, Bayley L and Haynes RB13      RCT = randomised controlled trial. 
 
Evidence pyramids, like the 6S Pyramid (Fig. 1), provide structures for finding suitable evidence to 
answer PICO questions.14 Further explanation and details about where you can find evidence from 
eaĐh leǀel aƌe giǀeŶ iŶ Taďle 3.  The uppeƌ leǀels of the pǇƌaŵid ƌelate to ͚͛aggƌegated͛͛ eǀideŶĐe, 
such as up-to-date evidence-based guidelines and systematic reviews, whilst the lower levels relate 
to individual original studies. At the top of the pyramid, the pre-appraised, synthesised information 
is more desirable and convenient for answering a question in a limited time period. However, for 
very specific PICO questions, evidence is more likely to be found at the lower levels of the pyramid. 
At the base of the pyramid are single studies. There are many databases which can be searched in 
order to find single studies (see Table 3). It is not mandatory to use more than one, thus a search in 
PubMed alone is sufficient. However, if you are searching more than one database, there are ways 
to prevent duplication of search results usiŶg ĐitatioŶ ŵaŶageƌs suĐh as ͚‘efǁoƌks͛ 
(www.refworks.com), ENDNOTE,  oƌ ͚MeŶdeleǇ͛ ;www.mendeley.com). 
 It is helpful to remember that disease-specific databases also exist. These include the GREAT 
database for atopic eczema (www.greatdatabase.org.uk).  
Systems
Summaries
Synopsies of 
syntheses
Syntheses
Synopses of single studies
Single studies
In practice, the best approach for a CAT is to check aggregate evidence first. If no evidence 
answering the PICO is found, the next step is to search for single studies. If a systematic review or 
other aggregated evidence is found it can be appraised and included in the CAT. If the aggregate 
evidence is older, single studies can be searched form the search date of this study.  
 
Finding the best available evidence: the search terms  
Based on the focused PICO question, the key search terms can then be identified. These are the 
terms to be entered into online databases and determine the relevance of the results. Often using 
the search terms for the P and I part of the PICO question is sufficient. For aggregated evidence 
fewer elements (just the P or the I) may do. In case of a large number of hits, additional elements 
can be added to refine the search results.   
It is important to include alternative names for the disease, diagnostic test or treatment to avoid 
missing relevant evidence. It is also important to consider alternative spellings. The Boolean 
opeƌatoƌ ͞O‘͟ is used to ĐoŵďiŶe seaƌĐh teƌŵs, foƌ eǆaŵple ͚spideƌ aŶiŵa͛ O‘ ͚spideƌ Ŷaeǀus͛ O‘ 
͚spideƌ Ŷeǀus͛.  “oŵe dataďases alloǁ tƌuŶĐatioŶ ;ĐoŵŵaŶd: *Ϳ at the eŶd of the teƌŵ to alloǁ foƌ 
spelling variants. 
In MEDLINE,PubMed, EMBASE and CENTRAL it is essential to make proper use of controlled terms 
(i.e. MeSH-terms in MEDLINE) and to use field codes, like [tiab] (title and abstract) to define the 
fields to be searched and to prevent automatic translation by PubMed. A PubMed search for atopic 
dermatitis should basically be as follows: 
"Dermatitis, Atopic"[Mesh] OR atopic dermat*[tiab] OR atopic neurodermatit*[tiab] OR 
eczem*[tiab]  
The final terms can then be combined using the Boolean operatoƌ ͞AND͟ to Đoŵplete the seaƌĐh. 
Those who are inexperienced in performing this type of search should seek assistance and guidance 
from their local library Information Specialist. The sources the complete search strategy, key search 
terms, filters or limits applied and search date should all be documented and reported in the 
͚ŵethods͛ seĐtioŶ of a CAT. This also helps ǁith futuƌe seaƌĐh updates.  
Although most databases allow restriction to for instance language, study types (i.e. RCTs) or 
population (i.e. child), these limitations should be used with caution, since these may readily lead to 
missing relevant articles. It is more prudent to use broad search filters like the build-in clinical 
queries in PubMed, the Cochrane filters for identifying RCTs, paediatric search filters or to use no 
filter at all. 
 
Critical appraisal of the evidence 
Before performing your search, inclusion and exclusion criteria must be determined and 
documented. These criteria may include study type, minimum sample size and patient 
characteristics, treatment or test specifics, the comparator and outcomes of interest. If your search 
returns numerous results, these criteria will allow you to narrow them down to a small number of 
the most relevant articles to answer the clinical question. If the search relates to a commonly 
encountered clinical question but has failed to find any relevant results, this suggests an area where 
research is needed (or the search is insufficient). It is important to bring this to the attention of other 
dermatologists and academics, but a meaningful CAT does require an evidence base that can be 
appraised. As a guide, the following section has been divided into three questions which should be 
addressed in relation to each piece of evidence: 
1. Does this study address the PICO question? 
For any piece of evidence, the important data should firstly be extracted and noted. This includes: 
author(s), year of publication, study design, patient characteristics, aspects of the disease such as 
duration and severity, details of the intervention(s) and their comparator(s) such as dose, frequency 
and duration of a treatment or timing of diagnostic tests. Finally the outcome(s) parameters, 
including instruments used to measure outcome and the timing of outcome measurement. By 
extracting these data it will become clear whether the study addresses the PICO question.  
2. Were the study methods valid? 
This question relates to internal validity. The internal validity of a study is the extent to which the 
study minimises bias and confounding factors. Some study designs are inherently better at 
minimising bias than others. For instance, well-performed randomised controlled trials (RCTs) are 
the gold standard to assess the effectiveness of a treatment. For questions about diagnostic 
accuracy, cross-sectional study designs are more appropriate.  
In RCTs, the randomisation process removes the influence of known and unknown confounding 
factors. In addition, blinding of the physician and patient reduces performance and detection bias. 
Therefore, it is important to assess the methods of randomisation and blinding of patients, 
physicians and outcome assessors. Comparability of the study groups at baseline is also important to 
ensure they are not markedly different, despite the randomisation process and this can be improved 
by stratified randomisation. The proportion of participants lost from follow-up and use of intention 
to treat analysis should also be noted to assess for possible attrition bias.In addition to study design, 
the sample size, or number of participants, is important. If the study is not adequately powered then 
clinically important differences may not be detected.  
  
Retrospective studies are inherently prone to selection bias and are also at risk of recall bias. At the 
base of the hierarchy of evidence are uncontrolled case series, case reports and expert opinions, all 
of which are at high risk of bias.  
To aid the critical appraisal of different types of studies, a wide range of checklists are available, such 
as the Cochrane Risk of Bias tool for RCTs, Quality Assessment of Diagnostic Accuracy Studies 
(QUADAS) for diagnostic accuracy studies (http://annals.org/aim/article/474994/quadas-2-revised-
tool-quality-assessment-diagnostic-accuracy-studies), the Newcastle-Ottawa Scale (NOS) for case-
control and cohort studies related to aetiology and harm 
(http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp), and the Quality in Prognostic 
Studies (QUIPS) for cohort studies related to prognosis 
(http://www.biomedcentral.com/content/supplementary/1546-0096-12-19-S1.pdf), the AXIS tool 
for cross-sectional studies (http://bmjopen.bmj.com/content/bmjopen/6/12/e011458.full.pdf) and 
the CARE statement for case reports (http://www.care-statement.org/). In addition, websites such 
as the Critical Appraisal Skills Programme (CASP) tools website, (www.casp-uk.net), and the 
Enhancing the Quality and Transparency Of health Research (EQUATOR) website (www.equator-
network.org) provide links to checklists for critical appraisal of all main study types, which are listed 
in Table 4.  
Study types 
Randomised controlled trials 
Observational studies  Cohort studies   Case control studies  Cross-sectional studies  Case series  Case reports 
Table 4: A list of the main study types 
When assessing synthesised evidence, such as systematic reviews, the reliability of the conclusion is 
based on the presence of all of the relevant evidence and absence of selection bias, as well as the 
validity of the included studies. It is essential to ensure that thorough search techniques, without 
iŶappƌopƌiate liŵits oƌ eǆĐlusioŶs, haǀe ďeeŶ used.  The seaƌĐh ŵethods, as ǁell as the authoƌ͛s 
critical appraisal of the included studies should be clearly documented. Reasons should be given for 
exclusion of any studies. Meta-analyses may have been used to combine trial results, however, 
meta-analyses should not be performed if there is substantial heterogeneity between the included 
studies. If results are pooled, appropriate weighting should be given to larger, more robust studies. 
Checklists are also available to aid critical appraisal of synthesised evidence, such as AMSTAR 
(https://amstar.ca/Amstar_Checklist.php) for systematic reviews and AGREE II 
(http://www.agreetrust.org/agree-ii/) for guidelines.  
3. Are the results applicable to your patient? 
If a study has minimal bias and used appropriate methods, it is then necessary to ensure that the 
results can be applied to the real life scenario that initiated the CAT. This means ensuring that the 
specific P, I, C, and O elements of the patient encounter are sufficiently comparable to the evidence 
provided by the studies.  If the patient population in the studies is different from the patient in the 
PICO question then the results may not be relevant. Similarly, if the Intervention, Comparator or 
Outcomes are significantly different, then the results cannot be directly transferred to the original 
patient scenario.  
A fuƌtheƌ ƌesouƌĐe to aid iŶ appƌaisiŶg eǀideŶĐe aŶd is the CeŶtƌe foƌ EǀideŶĐe ďased MediĐiŶe͛s 
online worksheets (http://www.cebm.net/critical-appraisal/). These helpfully break down critical 
appraisal into the following parts:  
 Does this study address a clearly focused question?  Did the study use valid methods to address this question?  Are the valid results of this study important?  Are these valid, important results applicable to my patient or population? 
 
Interpreting and applying the results 
If the clinician is satisfied that the evidence is internally valid and applicable to their patient, the next step is to 
interpret and apply the results. For each piece of evidence, the following questions should be asked: What is 
the effect size of results? How significant and how precise are they? How will these results alter my patient 
care? 
The specific results of interest relate to the outcome in the PICO question. In therapeutic studies, the 
absolute risk and the number needed to treat are usually the values of most relevance to clinical 
practice. In diagnostic studies, the most important values are the sensitivity and specificity of a test. 
Results of meta-analyses are often displayed in forest plots, showing the overall effect size 
(represented by the vertical axis of the black summary diamond) and associated confidence interval 
(the horizontal axis of the diamond) across all included studies.  
A tool that can help to further assess the overall quality of the evidence and therefore the results is 
GRADE (Grading of Recommendations Assessment, Development and Evaluation). The GRADE 
system was developed to provide a transparent approach to grading quality of evidence and 
subsequent strength of recommendations. It uses a scoring system based on the study design, 
quality, consistency, directness and effect size to combine a number of studies, focusing on a specific 
outcome following a particular intervention. and determine how good the overall evidence is for a 
specific outcome. GRADE emphasises outcomes that are important to patients. The overall quality of 
evidence, and therefore certainty of the result, is rated as high, moderate, low or very low. 
Furthermore, information and tutorials can be found at www.gradeworkinggroup.org.15  
Informed by the results of the CAT, a discussion with the patient can now take place to jointly agree 
the best management or diagnostic plan. It is this final stage which relates the evidence back to the 
patient and the clinical scenario from which the PICO question arose.  
 
Summary 
In summary, CATs are short structured summaries of critically appraised evidence based on patient 
encounters. They follow a systematic approach, can be produced in a relatively short time and 
should be easy to assimilate. However, CATs also have several disadvantages. Unlike systematic 
reviews, they only provide a selected synthesis of the overall evidence. In addition, the external 
generalisability of a CAT to any individual practice setting must be carefully considered. 
Nevertheless, a well-performed CAT, based on a question generated by a patient, provides evidence-
based guidance to improve the care of patients in a similar situation. Performing the CAT process 
itself enhances our skills in building critical appraisal and our understanding of clinical topics. CATs 
can aid learning at a local level, via teaching sessions and journal clubs, and can impact nationally 
and internationally via publication in journals such as the BJD.  
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 Table 2: Examples of PICO questions from CATs published in the British Journal of Dermatology 
  
Question Population Intervention Comparison Outcomes 
How effective is intralesional injection of 
triamcinolone acetonide compared with topical 
treatments in inducing and maintaining hair growth 
in patients with alopecia areata?8 
Patients with alopecia 
areata 
Intralesional triamcinolone 
acetonide 
 
 
 
All topical treatments  Induction and maintenance of 
hair re-growth 
 
 
Frequency and reversibility of 
adverse events 
 
In a patient with an immunobullous disorder, is 
transportation of the skin biopsy in normal saline 
adequate for direct immunofluorescence analysis?9 
Patients who have had a 
skin biopsy for an 
immunobullous disorder 
Transport of the skin biopsy 
to the laboratory in saline 
Transport of the skin 
biopsy to the 
laboratory in liquid 
nitrogen  
Relative diagnostic sensitivity of 
samples transported in the 
different mediums 
Dose House dust mite reduction improve symptom 
severity in patients with atopic dermatitis?10 
Patients with atopic 
dermatitis 
House dust mite reduction No house dust mite 
reduction 
Patients symptom severity 
based on SCORAD or  Leicester 
Sign Score 
Is Mohs micrographic surgery more effective than 
wide local excision for treatment of 
dermatofibrosarcoma protuberans in reducing risk 
of local recurrence?11 
Patients with 
dermatofibrosarcoma 
protruberans 
Mohs micrographic surgery Wide local excision Rate of local recurrence at 3 
years follow up 
Does paternal exposure to 
azathioprine (AZA), methotrexate (MTX) or 
mycophenolic acid (MPA) during/before conception 
lead to adverse pregnancy and postnatal 
outcomes?12 
Male patients who  have 
conceived a child whilst 
on immunosuppressive 
medication  
Azathioprine Methotrexate 
mycophenolic acid 
pregnancy outcomes (risk of 
preterm birth, stillbirth, 
spontaneous abortion) 
 
fetal and neonatal outcomes 
(birth weight ,congenital 
malformations, morbidity) 
6S pyramid level Explanation Examples of where the evidence can be found 
Systems Systems are databases that can integrate 
the best evidence based information with  
patieŶts͛ iŶdiǀidual ĐiƌĐuŵstaŶĐes 
 
Summaries Summaries are up-to-date guidelines or 
online texts which use the best evidence 
based information related to a clinical 
topic 
General guidelines:  Guidelines International Network  (GIN) database  National Institute for Clinical Excellence (NICE)  Scottish Intercollegiate Guidelines Network (SIGN)  National Guideline Clearinghouse 
Dermatology specific guidelines:  European Dermatology Forum (EDF)  American Academy of Dermatology (AAD) guidelines  British Association of Dermatologists (BAD)  Nederlandse Vereniging voor Dermatologie en Venereologie (NVDV) databases.   
 
Synopses of syntheses Synopses of systematically reviewed 
evidence articles 
Cochrane summaries 
 
Syntheses An article which systematically reviews the 
available evidence related to one clinical 
question 
Cochrane Database of Systematic Reviews 
Cochrane Skin Group (CSG) database 
Turning Research into Practice (TRIP) database 
Disease specific databases:  GREAT database for atopic dermatitis (www.greatdatabase.org.uk) (SRs on eczema)  
Synopses of single 
studies 
Synopses  and critical appraisals of  robust 
original studies 
Turning Research into Practice (TRIP) database 
ACP journal club 
Single studies The original research study investigating a 
particular clinical question e.g. a 
randomised controlled trial.  
Accessed through general databases:   (EMBASE)MEDLINE i.e. via Pubmed or OVID 
(CENTRAL of the Cochrane Library   (for RCTs 
Disease specific databases:  GREAT database for atopic dermatitis (www.greatdatabase.org.uk)  
 
Table 3: Sources of evidence from different levels of the 6S pyramid  
 
